CT SB00379 | 2024 | General Assembly
Status
Spectrum: Bipartisan Bill
Status: Introduced on March 7 2024 - 25% progression
Action: 2024-03-25 - Favorable Change of Reference, House to Committee on Finance, Revenue and Bonding
Pending: Joint Finance, Revenue and Bonding Committee
Text: Latest bill text (Comm Sub) [PDF]
Status: Introduced on March 7 2024 - 25% progression
Action: 2024-03-25 - Favorable Change of Reference, House to Committee on Finance, Revenue and Bonding
Pending: Joint Finance, Revenue and Bonding Committee
Text: Latest bill text (Comm Sub) [PDF]
Summary
To increase the rate of the credit refund value for research and experimental expenditures or research and development expenses of biotechnology companies.
Title
An Act Increasing The Rate Of The Credit Refund Value For Certain Expenditures By Biotechnology Companies.
Sponsors
Roll Calls
2024-03-22 - Joint - CE Vote Tally Sheet (Joint Favorable Change of Reference) (Y: 24 N: 0 NV: 0 Abs: 0) [PASS]
2024-03-21 - Joint - CE Vote Tally Sheet (Joint Favorable Change of Reference) (Y: 0 N: 0 NV: 0 Abs: 0) [PASS]
2024-03-21 - Joint - CE Vote Tally Sheet (Joint Favorable Change of Reference) (Y: 0 N: 0 NV: 0 Abs: 0) [PASS]
History
| Date | Chamber | Action |
|---|---|---|
| 2024-03-25 | Senate | Favorable Change of Reference, House to Committee on Finance, Revenue and Bonding |
| 2024-03-25 | Senate | Favorable Change of Reference, Senate to Committee on Finance, Revenue and Bonding |
| 2024-03-25 | Senate | Reported Out of Legislative Commissioners' Office |
| 2024-03-22 | Senate | Filed with Legislative Commissioners' Office |
| 2024-03-21 | Senate | Joint Favorable Change of Reference Finance, Revenue and Bonding |
| 2024-03-08 | Senate | Public Hearing 03/14 |
| 2024-03-07 | Senate | Referred to Joint Committee on Commerce |
